Login

Elias Papatheodorou, CEO of Genkyotex, tells us more about his relationship with the BioDiscovery team 00:00:00

Share On Facebook Share On Twitter

BioDiscovery by Elias Papatheodorou, CEO of Genkyotex

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
How Project 44 and Amber Road Add More Value for Their Clients | Andrew Appel, Chief Executive Officer, Amber Road Inc AMBR:NYQ
00:10:00
Investing in and building groundbreaking companies at their best|Ammar Amdani,Managing Partner,Adapt Ventures
00:10:00
Michał Rakowski Reviews First-Half 2019 Financial Results | Michał Rakowski, CFO, Amica SA.
00:10:00
Navigating Wealth Management with Alex Chaloff, CIO of Bernstein Private Wealth Management
00:10:00
Michael Roberts, CEO of HSBC USA and Americas, discusses the strategies he's implemented to transform operations across the US and Americas.
00:10:00
Exploring Chile: Montero Mining's Early-Stage Copper-Molybdenum Project
00:10:00
Strategies for Managing Health Care Expenses in Retirement | David W. Shotwell, CEO, Shotwell Rutter Baer.
00:10:00
Companies That Transform: Alicorp Discusses Its Winning Initiative | Alfredo Perez Gubbins, CEO, ALi Corp3041:TAI
00:10:00
Attico Mining: Mid-Tier Copper and Gold Producer with Promising High-Grade VMS Projects
00:10:00
From Sitcoms to Investment Management: Robert Stoll's Journey | Robert Stoll, CIO, Financial Design Studio.
00:10:00
The first appearance of SUSE CEO, Nils Brauckmann, on TFIR's Let's Talk!|Dirk-Peter van Leeuwen (“DP”) is Chief Executive Officer of SUSE
00:00:00
Satyajit T. Reddy, M.D. Cardiologist, Mayo Clinic

© 2026 Nehu